Lipoproteínas de alta densidad y riesgo cardiovascular.

Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives.

Frontiers in pharmacology·2026

2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk?

Archives of medical science : AMS·2026

The prevalence of obesity and its relationship to cardiometabolic risk factors in the LIPIDOGRAM studies.

Kardiologia polska·2026

Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies.

Current cardiology reports·2026

Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP).

Progress in cardiovascular diseases·2025

The Metabolic Vulnerability Index (MVX) in Subclinical Thyroid Disorders and Euthyroidism: A Cross-Sectional Exploratory Analysis from the ELSA-Brasil Study.

Metabolites·2025

Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives.

Circulation·2026

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.

Circulation·2026

Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association.

Circulation·2026

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association.

Circulation·2026

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Circulation·2026

No Germs, Just Cytokines: A Case of Immunotherapy-Induced Hemophagocytic Lymphohistiocytosis Masquerading as Neutropenic Sepsis in a Patient With Inflammatory Breast Cancer.

Cureus·2026

LigaSure™ Hemorrhoidectomy for Complex Grade III Hemorrhoidal Disease: A Prospective, Single-Center, Cohort Study.

Cureus·2026

Study on the predictive value of femoral head HU values in hip fractures.

Frontiers in surgery·2026

Atrial volume reduction correlates with early improvement in hemorrhage-associated normal pressure hydrocephalus-a 3D computed tomography volumetric study.

Frontiers in neurology·2026

Radially adjustable Tigertriever demonstrates higher reperfusion compared to self-expanding stent-retrievers during mechanical thrombectomy of large vessel occlusions: a systematic review and meta-analysis.

Frontiers in neurology·2026

Diabetes-duration-related shifts in inflammation-resolving lipid mediator signatures and their association with 3-month functional outcome in large artery atherosclerotic stroke.

Frontiers in neurology·2026

Videos de Experimentos Relacionados

Lipoproteínas de alta densidad y riesgo cardiovascular.

Videos de Conceptos Relacionados

Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives.

2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk?

The prevalence of obesity and its relationship to cardiometabolic risk factors in the LIPIDOGRAM studies.

Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies.

Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP).

The Metabolic Vulnerability Index (MVX) in Subclinical Thyroid Disorders and Euthyroidism: A Cross-Sectional Exploratory Analysis from the ELSA-Brasil Study.

Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives.

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.

Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association.

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association.

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

No Germs, Just Cytokines: A Case of Immunotherapy-Induced Hemophagocytic Lymphohistiocytosis Masquerading as Neutropenic Sepsis in a Patient With Inflammatory Breast Cancer.

LigaSure™ Hemorrhoidectomy for Complex Grade III Hemorrhoidal Disease: A Prospective, Single-Center, Cohort Study.

Study on the predictive value of femoral head HU values in hip fractures.

Atrial volume reduction correlates with early improvement in hemorrhage-associated normal pressure hydrocephalus-a 3D computed tomography volumetric study.

Radially adjustable Tigertriever demonstrates higher reperfusion compared to self-expanding stent-retrievers during mechanical thrombectomy of large vessel occlusions: a systematic review and meta-analysis.

Diabetes-duration-related shifts in inflammation-resolving lipid mediator signatures and their association with 3-month functional outcome in large artery atherosclerotic stroke.

Videos de Experimentos Relacionados

Lipoproteínas de alta densidad y riesgo cardiovascular.

Videos de Conceptos Relacionados

Artículos Relacionados